Bouée-Index®
Comprehensive financial data covering most pharmaceutical companies quoted on the American, Japanese, and European stock markets.
Bouée-Index, encompasses the company's sales, sales growth, profit,
R & D investments and shareholders equity, and matches this mix with the
company stock value.
The higher the Index, the cheaper the stock (as compared to its actual
value); however, a low index may result from factors not integrated in
the index, such as an especially valuable pipeline.
Original indices and composites developed by Bouée give an excellent ability to compare companies over time and across borders. Data is collected from the public domain and updated annually. Historical data back to 1984 is available for most companies.
Warning: Bouée-Index is much broader than most indicators (such as price-earning, etc.), and provides a meaningful initial guidance. But, as all similar tools, Bouée-Index requires its user to further perform a thourough analysis on selected targets.
Register to receive update notification and access the publication